Scholarlink

Sublocade® is the first long-acting injectable buprenorphine product for the treatment of moderate to severe opioid disorder. Sublocade® delivers a steady level of medication to help reduce cravings and withdrawal symptoms, supporting long-term recovery. This chapter provides clinical pearls on how to appropriately prescribe and administer Sublocade®.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Buprenorphine Extended Release (Sublocade®): C-III Controlled Medication

  • 章节

  • 发表日期：

    2025年

查看全文
  • Megan J. Ehret

摘要

Sublocade® is the first long-acting injectable buprenorphine product for the treatment of moderate to severe opioid disorder. Sublocade® delivers a steady level of medication to help reduce cravings and withdrawal symptoms, supporting long-term recovery. This chapter provides clinical pearls on how to appropriately prescribe and administer Sublocade®.